OOIR: Observatory of International Research

Papers

(The H4-Index of Thrombosis Research is 26. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)

Article	Citations
Is all collagen the same for platelet testing? Editorial on “Platelet collagen receptors and their role in modulating platelet adhesion patterns and activation on alternatively processed collagen subs	72
Distinct Immunologic Mediators Are Associated with Venous Thromboembolism in Multiply Injured Patients	60
Crosstalk between hemostasis and immunity in cancer pathogenesis	56
The role of interleukin-10 gene variants in inhibitor development in hemophilia: A meta-analysis	48
Acute and subacute effects of strenuous exercise on platelet aggregation, coagulation and fibrinolysis in patients with stable coronary artery disease	46
Rivaroxaban plus aspirin versus acenocoumarol to manage recurrent venous thromboembolic events despite systemic anticoagulation with rivaroxaban	44
Corrigendum to “Repurposing of rilpivirine for preventing platelet β3 integrin-dependent thrombosis by targeting c-Src active autophosphorylation” [Thromb. Res. 229 (2023) 53–68]	44
PO-08: Characterisation of plasma extracellular vesicles in myeloproliferative neoplasms	42
A novel role of acellular hemoglobin in hemolytic thrombosis	42
PO-51: Kaposiform hemangioendothelioma is associated with platelet functional abnormalities that persist in patients even after complete blood cell count recovery	41
Vaccine-induced immune thrombocytopenia and thrombosis after mRNA-1273 booster vaccination	40
Major in-hospital bleeding in patients with pulmonary embolism treated with systemic thrombolysis	36
PO-39: Superior vena cava stenting: an effective and safe therapeutic choice for the treatment of superior vena cava syndrome in lung cancer patients	34
DOACs: A perfect fit for patients with bariatric surgery?	34
Decreased patency of transjugular intrahepatic portosystemic shunts performed for splanchnic vein thrombosis in patients with myeloproliferative neoplasms	33
Linezolid impair proplatelet formation by reducing mitochondrial energy metabolism in MEG-01 cells	31
Regulation of fibrinogen synthesis	31
Cost of immune tolerance induction according to its outcome in people with hemophilia A and inhibitors: results from the Co$tIT study	30
Validation of the Academic Research Consortium for High Bleeding Risk criteria in Chinese patients with atrial fibrillation and acute coronary syndrome or undergoing percutaneous coronary intervention	30
Investigation of the impact of antithrombin deficiency on the inflammatory response: Results from a single centre cohort study	30
Assessing the risk of venous thromboembolism in trans masculine persons on gender-affirming hormone therapy: A literature review	29
Unveiling the predictive capacity of inflammatory and platelet markers for central retinal artery occlusion	29
Clinical outcomes of cancer-associated isolated superficial vein thrombosis in daily practice	29
Predicting post-discharge venous thromboembolism and bleeding among medical patients: External validation of a novel risk score utilizing ubiquitous biomarkers	28
Editorial Board	28

Clonal hematopoiesis and cardiovascular disease in cancer patients and survivors	28
Cyclophosphamide vs rituximab for eradicating inhibitors in acquired hemophilia A: A randomized trial in 108 patients	26